mucopolysaccharidosis


Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.
Related to mucopolysaccharidosis: mucopolysaccharidosis type 6, Hurler syndrome, Sphingolipidoses

mucopolysaccharidosis

[¦myü·kō‚päl·ē‚sak·ə·rə′dō·səs]
(medicine)
Any of several inborn metabolic disorders involving mucopolysaccharides; the six types are MPS I, Hurler's syndrome; MPS II, Hunter's syndrome; MPS III, Sanfillipo's syndrome; MPS IV, Morquio's syndrome; MPS V, Scheil's syndrome; and MPS VI, Maroteaux-Lamy's syndrome.
References in periodicals archive ?
Devise corrective measures for pipeline projects by understanding Mucopolysaccharidosis pipeline depth and focus of Indication therapeutics.
Devise corrective measures for pipeline projects by understanding Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) pipeline depth and focus of Indication therapeutics.
Devise corrective measures for pipeline projects by understanding Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) pipeline depth and focus of Indication therapeutics.
a pharmaceutical company developing an enzyme replacement therapy (ERT) for Mucopolysaccharidosis (MPS) IVA (Morbus Morquio) was founded in March 2006, as a spin-off of Inotech Biotechnologies AG.
Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Clinical Trials by End Point Status 24 Unaccomplished Trials of Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome ) 25 Subjects Recruited Over a Period of Time 27 Clinical Trials by Sponsor Type 28 Prominent Sponsors 29 Top Companies Participating in Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome ) Therapeutics Clinical Trials 30 Prominent Drugs 31 Clinical Trial Profiles 32 Clinical Trial Overview of Top Companies 32 BioMarin Pharmaceutical Inc.
About Hunter Syndrome Hunter syndrome, or mucopolysaccharidosis type II (MPS II), is a serious genetic disorder that primarily affects males (X-linked recessive).
He successfully led BioMarin during its Phase II and Phase III clinical studies with a lead product Phenoptin for treatment of phenylketonuria (PKU), an inherited metabolic disease, whilst simultaneously filing marketing drug applications in the US and Europe for Naglazyme, an enzyme replacement therapy for mucopolysaccharidosis VI (MPS 6).
The report provides an in-depth analysis of the Gaucher Disease Type 1, Niemann Pick Type C, Fabry Disease, Pompe Disease and Mucopolysaccharidosis VI Disease.
The manufacturing step that incorporates the Pall Mustang(R) Q ion exchange membrane was able to remove DNA to more than 100 million-fold below the level of detection, enabling BioMarin to insure the purity of Aldurazyme(R) (laronidase), an enzyme replacement therapy for the treatment of the genetic disorder mucopolysaccharidosis I.
These include Fabry Disease, Pompe Disease and Mucopolysaccharidosis VI, Idiopathic Thrombocytopenic Purpura, Huntington's disease and Ovarian Cancer.
A friendship between Adams Golf (OTCBB:ADGO) founder Barney Adams and one special child, Ryan Dant, has led to continued support by Adams Golf for children and families battling Mucopolysaccharidosis (MPS), a disease that affects some 100,000 children around the world and is generally fatal by age 12.

Full browser ?